Health Condition 1: null- Keloids
Conditions
Interventions
Intervention1: Triamcinolone acetonide: Dose of 40 mg/ml given by intralesional route, every 3 weeks for a maximum duration of 24 weeks
Intervention2: 5-fluorouracil: Dose of 50 mg/ml given by intrale
Sponsors
Sawai Man Singh Medical College Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: keloids of size 1 to 10 cm in greatest dimension, keloids of >6 months duration
Exclusion criteria
Exclusion criteria: Hypertrophic scars, Females who were pregnant or were planning pregnancy, Patients who had received treatment for the same keloid in the past 12 months, Patients who had active inflammation, infection or ulcer in or around the keloid, Immunosuppressed patients, Patients with chronic inflammatory diseases, Patients with renal or liver failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Keloid height, vascularity, pliability and pigmentation using Vancouver Scar scale Pain PruritusTimepoint: Every 3 weeks for 24 weeks and 30 weeks after first dose | — |
Secondary
| Measure | Time frame |
|---|---|
| Keloid height, vascularity, pliability and pigmentation using Vancouver Scar scale Pain PruritusTimepoint: 30 weeks after first dose | — |
Countries
India
Contacts
Public ContactAditya Patil
Sawai Man Singh Medical College and Hospital
Outcome results
None listed